Skip to content

Sartorius Stedim Biotech Shares Fall After Capital Increase – Morningstar

Sartorius Stedim Biotech Shares Fall After Capital Increase – Morningstar

 

 By Nina Kienle Sartorius Stedim Biotech shares dropped Wednesday after the France-based laboratory-instrument manufacturer completed a capital increase of 1.2 billion euros ($1.29 billion). At 0843 GMT, shares were down 3% at EUR243.50, above the price at which the company sold its new shares,… 

Read More